SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044747
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:51
Documents
45
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 491769
2 ex31-1.htm EX-31.1 11997
3 ex31-2.htm EX-31.2 12113
4 ex32-1.htm EX-32.1 6443
5 ex32-2.htm EX-32.2 6493
  Complete submission text file 0001493152-24-044747.txt   2492131

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mira-20240930.xsd EX-101.SCH 20972
7 XBRL CALCULATION FILE mira-20240930_cal.xml EX-101.CAL 29675
8 XBRL DEFINITION FILE mira-20240930_def.xml EX-101.DEF 80873
9 XBRL LABEL FILE mira-20240930_lab.xml EX-101.LAB 177472
10 XBRL PRESENTATION FILE mira-20240930_pre.xml EX-101.PRE 140092
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 248884
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 001-41765 | Film No.: 241447996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)